Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PF-06412528 IN CHILDREN 7-17 YEARS FOR THE TREATMENT OF MODERATE-TO-SEVERE PAIN

NCT02101554 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02101554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02101554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PF-06412528 IN CHILDREN 7-17 YEARS FOR THE TREATMENT OF MODERATE-TO-SEVERE PAIN
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
April 24, 2015
Completion date
June 26, 2019
Enrollment
19 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

moderate-severe pain